[CITATION][C] The addition of cetuximab to cisplatin increases overall response rate (ORR) and progression-free survival (PFS) in metastatic triple-negative breast …

J Baselga, P Gomez, A Awada… - Annals of …, 2010 - OXFORD UNIV PRESS GREAT …
Save Cite Cited by 68 Related articles